BERNARDI, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.272
AS - Asia 3.967
EU - Europa 2.049
SA - Sud America 601
Continente sconosciuto - Info sul continente non disponibili 127
AF - Africa 105
OC - Oceania 5
Totale 16.126
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.026
SG - Singapore 1.186
HK - Hong Kong 817
CN - Cina 684
VN - Vietnam 456
BR - Brasile 432
GB - Regno Unito 373
IT - Italia 366
BD - Bangladesh 302
SE - Svezia 296
FI - Finlandia 261
RU - Federazione Russa 176
DE - Germania 119
KR - Corea 113
CA - Canada 111
BG - Bulgaria 92
FR - Francia 73
IN - India 69
AR - Argentina 66
NL - Olanda 47
JP - Giappone 44
IQ - Iraq 41
ID - Indonesia 39
AE - Emirati Arabi Uniti 37
ZA - Sudafrica 37
MX - Messico 34
PL - Polonia 31
UA - Ucraina 30
IE - Irlanda 28
TR - Turchia 27
AT - Austria 25
BE - Belgio 24
CO - Colombia 24
PK - Pakistan 23
ES - Italia 22
CL - Cile 19
EC - Ecuador 17
CR - Costa Rica 15
LT - Lituania 15
HN - Honduras 14
IL - Israele 14
MY - Malesia 14
VE - Venezuela 14
CZ - Repubblica Ceca 13
DZ - Algeria 13
EG - Egitto 13
SA - Arabia Saudita 13
GT - Guatemala 12
PY - Paraguay 12
JM - Giamaica 11
TT - Trinidad e Tobago 11
KE - Kenya 10
PH - Filippine 10
UZ - Uzbekistan 10
IR - Iran 9
KZ - Kazakistan 9
MA - Marocco 9
AZ - Azerbaigian 7
ET - Etiopia 7
JO - Giordania 7
NO - Norvegia 7
RO - Romania 7
SV - El Salvador 7
TN - Tunisia 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
PE - Perù 6
PR - Porto Rico 6
CH - Svizzera 5
DK - Danimarca 5
NI - Nicaragua 5
NP - Nepal 5
RS - Serbia 5
AU - Australia 4
BO - Bolivia 4
BY - Bielorussia 4
EE - Estonia 4
GP - Guadalupe 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
HU - Ungheria 3
KG - Kirghizistan 3
LB - Libano 3
LK - Sri Lanka 3
MD - Moldavia 3
OM - Oman 3
SC - Seychelles 3
TH - Thailandia 3
BS - Bahamas 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
GE - Georgia 2
GR - Grecia 2
LV - Lettonia 2
MK - Macedonia 2
PS - Palestinian Territory 2
PT - Portogallo 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
Totale 15.981
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.191
Ashburn 1.121
Hong Kong 808
Singapore 771
Fairfield 552
Chandler 548
San Jose 469
Council Bluffs 267
Helsinki 255
Nyköping 255
London 221
Woodbridge 209
Houston 201
Wilmington 196
Seattle 168
Cambridge 159
Beijing 153
Los Angeles 153
New York 153
Ann Arbor 148
Ho Chi Minh City 140
The Dalles 125
Boardman 121
Hanoi 116
San Diego 116
Chicago 112
Seoul 109
Princeton 92
Sunnyvale 92
Sofia 91
Oakland 77
Buffalo 68
Milan 61
Hefei 60
Orem 55
North Bergen 52
Salt Lake City 52
Dallas 50
Moscow 47
São Paulo 45
Shanghai 42
Southend 41
Jersey City 35
Bremen 33
Saint Augustine 33
Phoenix 32
Tokyo 30
Rome 29
Dearborn 28
Toronto 28
Atlanta 27
Da Nang 27
Dublin 26
Tampa 24
Brussels 23
Johannesburg 23
Haiphong 22
Jakarta 22
Warsaw 22
Chennai 21
Redondo Beach 21
Washington 21
Reading 20
San Francisco 20
Brooklyn 19
Frankfurt am Main 18
Amsterdam 17
West Bloomfield 17
Montreal 16
Bologna 15
Denver 14
Detroit 14
Elk Grove Village 14
Jacksonville 14
Mexico City 14
Miano 14
Newark 14
Philadelphia 14
Rio de Janeiro 14
Groningen 13
Lauterbourg 13
Manchester 13
Paris 13
Vienna 13
Biên Hòa 12
Brno 12
Miami 12
San José 12
Stockholm 12
Des Moines 11
Las Vegas 11
Norwalk 11
Vancouver 11
Charlotte 10
Falkenstein 10
Florence 10
Nairobi 10
North Charleston 10
Pittsburgh 10
Baghdad 9
Totale 10.795
Salva come PNG Salva come JPEG
Nome #
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 400
A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18. 353
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions 339
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 310
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool 299
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 289
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation 274
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B 270
Adaptive response in Hepatitis B virus infection 267
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 263
Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report 240
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma 240
Alcohol and viral hepatitis: a mini-review 238
A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of non-responder patients with chronic hepatitic C 237
CD 133+ stem cells for the treatment of end stage liver disease 228
Development of different psychiatric manifestations during antiviral therapy for chronic hepatitis C. 227
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis 222
Comparing and combining gamma-hydroxybutiric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomized comparative study 219
Chronic hepatitis B: Are we close to a cure? 213
Acquired intestinal lymphangiectasia successfully treated with a low fat and MCT-enriched diet in a patient with liver transplantation 213
Allocation priority in non urgent liver transplantation: an overview of proposed scoring systems 209
MARS and Prometheus: our clinical experience in acute chronic liver failure 203
In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C 200
Characterization of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver 199
Stem cell mobilization and collection in patients with liver cirrhosis 199
Liver transplantation for patients with alcoholic liver disease: an open question 197
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C 195
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients 193
An in-depth psychosocial and biochemical evaluation in transplant recipients for alcoholic liver disease should be planned 193
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 192
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B 191
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 187
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival 182
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels 180
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? 180
Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from a 20-year multicentre experience in Italy 179
Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection 177
Serum hepatitis B surface antigen monitoring in long-term Lamivudine-treated hepatitis B virus patients 176
Bone marrow derived stem cells for the treatment of end-stage liver disease 176
Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naive and non-responder patients on a stable immunosuppressive regimen 176
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance 175
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness 172
Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection 169
Polymorphism rtQ215H in primary resistance to adefovir dipivoxil in hepatitis B virus infection: a case report 168
Genetic variability of hepatitis C virus in HBV/HCV co-infection and HCV single-infection 167
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 165
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner? 164
Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C 164
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation 162
Hepatitis C in the elderly: a multicenter cross-sectional study by the Italian Association for the Study of the Liver 162
Hepatitis B virus and immune response 161
Ketoprofen, peginterferon-alpha2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study 160
Role of Contrast-Enhanced Ultrasonography in Primary Hepatic Lymphoma 158
Trattamento dell’epatopatia alcolica 157
Review article: Alcoholic liver disease - Pathophysiological aspects and risk factors 155
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study 154
Hepatocellular carcinoma in patients with cryptogenic cirrhosis 150
The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis 150
Immunological modifications during treatment with thymosin alpha 1 plus antiviral therapy in chronic hepatitis C 148
Genetic heterogeneity of hepatitis C virus in HBV/HCV co-infection 147
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study 146
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case controlled study 145
Virological analysis, genotypes and mutational patterns of the HBV pre-core/core gene in HBV/HCV-related hepatocellular carcinoma 145
Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: a phase I clinical trial 143
High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? 143
Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin 142
Human herpesvirus-8-related Kaposi’s sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin 142
Two yr mycophenolate mofetil plus low-dose calcineurin inhibitor for renal dysfunction after liver transplant 141
Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial 138
OUTCOME OF LIVER TRANSPLANT FOR ALCOHOLIC LIVER DISEASE 137
Vitamins in the treatment of chronic viral hepatitis 129
High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing Lamivudine resistance 129
MUTATIONAL ANALYSIS OF THE HBV PRE-CORE/CORE GENE IN HBV/HCV-RELATED HEPATOCELLULAR CARCINOMA 128
Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study 128
Tenofovir-induced Fanconi syndrome in a patient with chronic hepatitis B monoinfection 126
Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophyl granulocytes in patients with liver cirrhosis 126
Post-transplantation lymphoproliferative disorders in liver transplanted patients: a report of four cases 123
Stem cells for end stage liver disease: How far have we got? 122
ECHO-COLOUR-DOPPLER CHARACTERIZATION OF CIRRHOTIC PATIENTS RESPONDERS AND NON-RESPONDERS TO NADOLOL AS PRIMARY PROPHYLAXIS 121
GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) ADMINISTRATION IN CIRRHOTIC PATIENTS: A PHASE II STUDY EVALUATING TOLERABILITY PROFILE AND MOBILIZATION OF HAEMATOPOIETIC STEM CELLS (HSCS) 121
Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses 117
Cryoglobulinemia in elderly patients with HCV-related chronic hepatitis 117
In portal hypertensive cirrhotic patients abdominal porto-systemic collaterals at ultrasound identify a group of patients at high risk of death 115
Sustained and focused HBV-nucleocapsid-specific T cell immunity in liver transplant recipients compared to individuals with chronic and self-limited HBV infection 114
OUTCOME OF LIVER TRANSPLANT FOR ALCOHOLIC LIVER DISEASE 113
Hepatic artery stenosis in liver transplanted patients treated with pegylated Interferon alpha-2b and Ribavirin 112
Evolution of hepatitis C vitus non structural 5A gene (NS5A) in the progression of liver disease to hepatocellular carcinoma 112
PEGYLATED INTERFERON PLUS RIBAVIRIN FOR THE TREATMENT OF RECURRENT HCV INFECTION AFTER LIVER TRANSPLANTATION 110
Hepatitis C virus (HCV) infection in elderly patients: A multicenter Italian cross-sectional study 109
Vitamin E as treatment for chronic viral hepatitis: is it time to perform large clinical trials? 99
Totale 16.126
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.561
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.020 0 0 0 0 11 86 90 85 207 185 193 163
2022/20231.378 188 174 101 137 160 225 11 126 174 4 44 34
2023/2024778 26 47 33 79 217 22 44 122 28 18 28 114
2024/20253.171 117 23 6 238 839 492 116 252 327 178 221 362
2025/20265.940 260 114 387 630 831 439 716 441 576 581 484 481
2026/20272.134 231 663 419 724 97 0 0 0 0 0 0 0
Totale 16.126